…
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | -14.74M | -13.85M | -7.45M | -20.40M |
| Minority interest | - | - | - | -4.57M |
| Net income | -14.74M | -13.85M | -7.45M | -24.96M |
| Selling general administrative | 10.75M | 11.58M | 10.25M | 8.40M |
| Gross profit | 5.07M | 4.74M | 4.50M | -0.17M |
| Reconciled depreciation | 0.77M | 0.27M | 0.15M | 0.08M |
| Operating income | -6.45M | -7.11M | -5.90M | -9.29M |
| Interest expense | 2.40M | 1.68M | 0.96M | 1.63M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | -2.40M | -1.68M | -0.96M | -1.63M |
| Total revenue | 16.93M | 27.88M | 18.61M | 1.20M |
| Cost of revenue | 11.86M | 23.14M | 14.11M | 1.36M |
| Total other income expense net | -4.89M | -5.05M | -0.62M | -9.21M |
| Net income from continuing ops | -14.74M | -13.85M | -7.45M | -20.40M |
| Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 30.56M | 15.04M | 19.61M | 10.42M |
| Intangible assets | 20.88M | 2.47M | 0.46M | 0.01M |
| Other current assets | - | 2.47M | - | 0.47M |
| Total liab | 27.42M | 14.45M | 15.25M | 10.67M |
| Total stockholder equity | 7.18M | 0.59M | 4.36M | -0.25M |
| Other current liab | 5.65M | - | - | - |
| Capital stock | 131.08M | 112.42M | 102.62M | 91.73M |
| Retained earnings | -127.45M | -115.56M | -101.71M | -94.49M |
| Good will | - | 0.99M | 5.00M | 0.47M |
| Cash | 0.90M | 0.32M | 3.18M | 7.78M |
| Total current liabilities | 27.34M | 14.30M | 9.80M | 10.55M |
| Net debt | 9.71M | 6.47M | 4.39M | 1.40M |
| Short long term debt | 10.62M | 6.79M | 2.38M | 9.18M |
| Total current assets | 9.49M | 11.38M | 13.84M | 9.82M |
| Net receivables | 4.33M | 4.14M | 5.69M | 0.21M |
| Long term debt | - | - | 5.20M | - |
| Inventory | 3.22M | 3.03M | 4.32M | 0.66M |
| Accounts payable | 7.44M | 6.35M | 5.71M | 0.81M |
| Non current assets total | 21.07M | 3.66M | 5.77M | 0.60M |
| Capital lease obligations | 0.05M | 0.16M | 0.28M | 0.13M |
| Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | - | - | -0.00M | -0.65M |
| Net borrowings | 3.58M | -1.80M | 6.33M | 2.94M |
| Total cash from financing activities | 20.82M | 5.53M | 7.66M | 1.65M |
| Net income | -14.74M | -13.85M | -7.45M | -24.96M |
| Change in cash | 0.58M | -2.86M | -4.59M | 6.66M |
| Begin period cash flow | 0.32M | 3.18M | 7.78M | 1.12M |
| End period cash flow | 0.90M | 0.32M | 3.18M | 7.78M |
| Issuance of capital stock | 20.15M | 8.17M | 2.18M | - |
| Sale purchase of stock | -2.80M | -0.71M | -0.17M | -1.22M |
| Capital expenditures | 0.00M | 0.00M | 0.04M | 0.79M |
| Free cash flow | -6.87M | -6.19M | -8.65M | -5.24M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| WNX Wellnex Life Limited |
-0.50 10.00% |
4.50 | - | - | 0.25 | 1.18 | 0.58 |
| ABF Associated British Foods PLC |
-39.00 1.98% |
1927.00 | 13.37 | 12.18 | 0.69 | 1.21 | 0.82 |
| KYGA Kerry Group |
-0.80 0.82% |
97.00 | 0.17 | 13.30 | 1.60 | 1.85 | 1.94 |
| MICC The Magnum Ice Cream Company N.V. |
-1.00 0.07% |
1449.00 | 25.07 | 13.30 | 0.82 | 12.11 | 1.31 |
| GLB Glanbia plc |
-0.80 3.85% |
20.00 | 0.28 | 12.38 | 1.08 | 2.44 | 1.36 |
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Port Park - Building 2, Port Melbourne, VIC, Australia, 3207
61 3 8399 9419
| Name | Title | Year Born |
|---|---|---|
| Ms. Yuan Zhang | Chief Financial Officer | NA |
| Mr. Zlatko Bozinovski | Chief Strategy Officer | NA |
| Mr. Zheng Li | Company Secretary | NA |
| Nick Krogh | Sales & Marketing Manager | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.